HYYR

Description

Indication: 

Treatment of Non-Small Cell Lung Cancer.

Combination with gemcitabin for treatment of Pancreatic cancer.

Contraindications: Hypersensitivity to any component of the drug.

Presentation: 3 blisters x 10 F.C. tablets

Storage: Store in a dry place at a temperature below 30°C. Protect from light.

Shelf-life: 36 months

Manufactured by:  DAVIPHARM – Viet Nam